BNKL - Bionik Laboratories Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
7.71M
Enterprise Value 3
3.1M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.36
Price/Book (mrq)
0.25
Enterprise Value/Revenue 3
0.95
Enterprise Value/EBITDA 6
-0.33

Trading Information

Stock Price History

Beta (5Y Monthly) -0.14
52-Week Change 3-76.15%
S&P500 52-Week Change 325.98%
52 Week High 3100.0000
52 Week Low 31.0100
50-Day Moving Average 31.4709
200-Day Moving Average 32.3519

Share Statistics

Avg Vol (3 month) 3203
Avg Vol (10 day) 3200
Shares Outstanding 54.98M
Float 2.5M
% Held by Insiders 175.95%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:150
Last Split Date 3Oct 29, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-300.58%

Management Effectiveness

Return on Assets (ttm)-19.16%
Return on Equity (ttm)-38.44%

Income Statement

Revenue (ttm)3.27M
Revenue Per Share (ttm)1.05
Quarterly Revenue Growth (yoy)-48.50%
Gross Profit (ttm)1.62M
EBITDA -9.46M
Net Income Avi to Common (ttm)-11.32M
Diluted EPS (ttm)-3.6270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.67M
Total Cash Per Share (mrq)0.94
Total Debt (mrq)70.12k
Total Debt/Equity (mrq)0.22
Current Ratio (mrq)2.58
Book Value Per Share (mrq)6.24

Cash Flow Statement

Operating Cash Flow (ttm)-9.17M
Levered Free Cash Flow (ttm)-6.41M